SKI Market

A+| A| A-|

Indian Indices

Sensex

78,493.54 504.86
( 0.65%)

Global Indices

Nasdaq

49,467.44 867.71
(1.79%)

Dow Jones

7,146.92 84.64
(1.20%)

Hang Seng

58,837.37 -680.97
(-1.14%)

Nikkei 225

10,660.47 70.48
(0.67%)

Forex

USD-INR

93.19 -0.12
(-0.13%)

EUR-INR

109.85 -0.18
(-0.16%)

GBP-INR

126.25 -0.31
(-0.25%)

JPY-INR

0.59 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

22.22

103113.52

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.65

Back

finolex industries ltd

Balkrishna Industries consolidated net profit declines 14.98% in the December 2025 quarter

Jan 29,2026

Net profit of Balkrishna Industries declined 14.98% to Rs 382.15 crore in the quarter ended December 2025 as against Rs 449.48 crore during the previous quarter ended December 2024. Sales rose 6.89% to Rs 2736.79 crore in the quarter ended December 2025 as against Rs 2560.33 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2736.79	2560.33	7
OPM %	23.50	23.46	-
PBDT	686.40	772.27	-11
PBT	491.06	599.68	-18
NP	382.15	449.48	-15

78,493.54 504.86 ( 0.65%)

49,467.44 867.71 (1.79%)

7,146.92 84.64 (1.20%)

58,837.37 -680.97 (-1.14%)

10,660.47 70.48 (0.67%)

93.19 -0.12 (-0.13%)

109.85 -0.18 (-0.16%)

126.25 -0.31 (-0.25%)

0.59 0.00 (-0.15%)